Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Terminated
- Conditions
- Cervix Cancer
- Registration Number
- NCT00571415
- Lead Sponsor
- Virginia Commonwealth University
- Brief Summary
Within this study patient data are collected from different imaging and motion monitoring devices that will be used to develop and test strategies for image-guided adaptive radiotherapy in cervix cancer patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 21
Inclusion Criteria
- Histological diagnosis of cervix cancer
- Prescription of radiation treatment to the primary cancer
Exclusion Criteria
- Prior radiation treatment to the pelvis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase in therapeutic ratio 5 years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular imaging techniques are used in NCT00571415 for cervix cancer radiotherapy adaptation?
How does image-guided adaptive radiotherapy in NCT00571415 compare to conventional cervix cancer radiation protocols?
What biomarkers correlate with treatment response in cervix cancer patients undergoing adaptive radiotherapy as studied in NCT00571415?
What are the most common adverse events associated with image-guided adaptive radiotherapy for cervix cancer?
What combination therapies are being explored alongside image-guided adaptive radiotherapy for cervix cancer treatment?
Trial Locations
- Locations (1)
Viriginia Commonwealth University, Department of Radiation Oncology
🇺🇸Richmond, Virginia, United States
Viriginia Commonwealth University, Department of Radiation Oncology🇺🇸Richmond, Virginia, United States